Insider Selling: Grail, Inc. (NASDAQ:GRAL) President Sells 2,109 Shares of Stock

Grail, Inc. (NASDAQ:GRAL) President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares in the company, valued at $17,461,797.60. This trade represents a 0.38 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Grail Stock Up 1.0 %

GRAL stock traded up $0.31 during trading on Wednesday, reaching $30.85. The company had a trading volume of 1,392,942 shares, compared to its average volume of 1,224,902. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The firm has a 50-day simple moving average of $31.16 and a 200-day simple moving average of $21.08.

Grail (NASDAQ:GRAL) last issued its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Hedge Funds Weigh In On Grail

Several hedge funds and other institutional investors have recently bought and sold shares of GRAL. Alpha Wealth Funds LLC acquired a new position in Grail during the fourth quarter valued at $2,562,000. Ameriflex Group Inc. purchased a new position in Grail during the fourth quarter valued at approximately $95,000. PVG Asset Management Corp acquired a new position in Grail in the fourth quarter valued at approximately $398,000. Public Employees Retirement System of Ohio purchased a new stake in Grail in the 4th quarter worth approximately $334,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Grail during the 4th quarter worth approximately $1,201,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Morgan Stanley started coverage on shares of Grail in a research note on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company. Wolfe Research began coverage on Grail in a report on Friday, November 15th. They set a “peer perform” rating for the company.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.